Terms: = Cervical cancer AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2
15 results:
1. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
[TBL] [Abstract] [Full Text] [Related]
2. FGF signalling facilitates cervical cancer progression.
Mahmood HA; Tomas Bort E; Walker AJ; Grose RP; Chioni AM
FEBS J; 2022 Jun; 289(12):3440-3456. PubMed ID: 34951738
[TBL] [Abstract] [Full Text] [Related]
3. Risk factors associated with the persistence of human papillomavirus after cervical excision in patients with high-grade squamous intra-epithelial neoplasia.
Zang L; Huang J; Zhu J; Hu Y
Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():175-181. PubMed ID: 34689015
[TBL] [Abstract] [Full Text] [Related]
4. High-sensitivity C-reactive Protein and Regression of Low-grade Squamous Intraepithelial Lesion: The Role of Low-grade Inflammation in cervical Carcinogenesis.
Ahn S; Kim GJ; Do SI; Kim K; Lee H; Do IG; Kim DH; Chae SW; Ryu S; Sohn JH
J Epidemiol; 2021 Dec; 31(12):615-620. PubMed ID: 33536377
[TBL] [Abstract] [Full Text] [Related]
5. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
[TBL] [Abstract] [Full Text] [Related]
6. Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix.
Park E; Kim SW; Kim S; Kim HS; Lee JY; Kim YT; Cho NH
Mod Pathol; 2021 Mar; 34(3):637-646. PubMed ID: 32641744
[TBL] [Abstract] [Full Text] [Related]
7. FGFR Signaling as a Candidate Therapeutic Target for cancers Resistant to Carbon Ion Radiotherapy.
Darwis NDM; Nachankar A; Sasaki Y; Matsui T; Noda SE; Murata K; Tamaki T; Ando K; Okonogi N; Shiba S; Irie D; Kaminuma T; Kumazawa T; Anakura M; Yamashita S; Hirakawa T; Kakoti S; Hirota Y; Tokino T; Iwase A; Ohno T; Shibata A; Oike T; Nakano T
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540114
[TBL] [Abstract] [Full Text] [Related]
8. Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women.
Kiweewa FM; Brown E; Mishra A; Nair G; Palanee-Phillips T; Mgodi N; Nakabiito C; Chakhtoura N; Hillier SL; Baeten JM;
J Int AIDS Soc; 2019 Feb; 22(2):e25257. PubMed ID: 30816632
[TBL] [Abstract] [Full Text] [Related]
9. Study on the Association between the Fibroblast Growth Factor Receptor 4 Expression and High-Risk Human Papillomavirus Infection in cervical cancer and Precancerous Lesions.
Guo L; Zhao A; Zhang R; Xie Y; Xu X
Gynecol Obstet Invest; 2018; 83(6):608-614. PubMed ID: 29982249
[TBL] [Abstract] [Full Text] [Related]
10. Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine cervical cancer and Patient Prognosis.
Chen TH; Yang SF; Liu YF; Lin WL; Han CP; Wang PH
Reprod Sci; 2018 Jan; 25(1):86-93. PubMed ID: 28378614
[TBL] [Abstract] [Full Text] [Related]
11. Iriomoteolides-9a and 11a: two new odd-numbered macrolides from the marine dinoflagellate Amphidinium species.
Kumagai K; Tsuda M; Fukushi E; Kawabata J; Masuda A; Tsuda M
J Nat Med; 2017 Jul; 71(3):506-512. PubMed ID: 28255848
[TBL] [Abstract] [Full Text] [Related]
12. Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.
Choi CH; Chung JY; Kim JH; Kim BG; Hewitt SM
J Transl Med; 2016 May; 14(1):124. PubMed ID: 27154171
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
Skinner SR; Szarewski A; Romanowski B; Garland SM; Lazcano-Ponce E; Salmerón J; Del Rosario-Raymundo MR; Verheijen RH; Quek SC; da Silva DP; Kitchener H; Fong KL; Bouchard C; Money DM; Ilancheran A; Cruickshank ME; Levin MJ; Chatterjee A; Stapleton JT; Martens M; Quint W; David MP; Meric D; Hardt K; Descamps D; Geeraerts B; Struyf F; Dubin G;
Lancet; 2014 Dec; 384(9961):2213-27. PubMed ID: 25189358
[TBL] [Abstract] [Full Text] [Related]
14. Ovarian metastasis and other ovarian neoplasms in women with cervical cancer stage IA-IIA.
Ngamcherttakul V; Ruengkhachorn I
Asian Pac J Cancer Prev; 2012; 13(9):4525-9. PubMed ID: 23167373
[TBL] [Abstract] [Full Text] [Related]
15. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and fgfr4.
Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
[TBL] [Abstract] [Full Text] [Related]
